CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders


Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 10 Issue: 3, May

Commentary (Research Highlights)

Volume:10   Issue: 3
Pp: 295-295
Stephen D. Skaper
DOI: 10.2174/187152711794653823
Published on: 01 March, 2012

Editorial [Hot Topic: Prolyl Oligopeptidase in Brain Function and Dysfunction (Guest Editor: J. Arturo Garcia-Horsman)]

Volume:10   Issue: 3
Pp: 296-296
J. Arturo Garcia-Horsman
DOI: 10.2174/187152711794653788
Published on: 01 March, 2012

Structure and Function Relationship in Prolyl Oligopeptidase

Volume:10   Issue: 3
Pp: 297-305
Roos Van Elzen and Anne-Marie Lambeir
DOI: 10.2174/187152711794653814
Published on: 01 March, 2012

Prolyl Oligopeptidase Structure and Dynamics

Volume:10   Issue: 3
Pp: 306-310
Dean Rea and Vilmos Fulop
DOI: 10.2174/187152711794653850
Published on: 01 March, 2012

Association of Prolyl Oligopeptidase with Conventional Neurotransmitters in the Brain

Volume:10   Issue: 3
Pp: 311-318
Iida Peltonen, Timo T. Myohanen and Pekka T. Mannisto
DOI: 10.2174/187152711794653887
Published on: 01 March, 2012

Hunting for Peptide Substrates of Prolyl Oligopeptidase: Classical Versus Non-Classical Bioactive Peptides

Volume:10   Issue: 3
Pp: 319-326
Jofre Tenorio-Laranga, Pekka T. Mannisto and J. Arturo Garcia-Horsman
DOI: 10.2174/187152711794653841
Published on: 01 March, 2012

Role of Prolyl Endopeptidase in Intracellular Transport and Protein Secretion

Volume:10   Issue: 3
Pp: 327-332
M. Morawski, I. Schulz, U. Zeitschel, M. Blosa, G. Seeger and S. Roßner
DOI: 10.2174/187152711794653805
Published on: 01 March, 2012

Prolyl Oligopeptidase, Inositol Phosphate Signalling and Lithium Sensitivity open access plus

Volume:10   Issue: 3
Pp: 333-339
Adrian J. Harwood
DOI: 10.2174/187152711794653779
Published on: 01 March, 2012

Prolyl Oligopeptidase: A Rising Star on the Stage of Neuroinflammation Research

Volume:10   Issue: 3
Pp: 340-348
Anne Penttinen, Jofre Tenorio-Laranga, Anssi Siikanen, Markus Morawski, Steffen Roßner and J. Arturo Garcia-Horsman
DOI: 10.2174/187152711794653742
Published on: 01 March, 2012

Interaction of Prolyl Oligopeptidase with α-Synuclein

Volume:10   Issue: 3
Pp: 349-354
Anne-Marie Lambeir
DOI: 10.2174/187152711794653878
Published on: 01 March, 2012

PREPL, a Prolyl Endopeptidase-Like Enzyme by Name Only? – Lessons from Patients

Volume:10   Issue: 3
Pp: 355-360
Kurt Boonen, Luc Regal, Jaak Jaeken and John W.M. Creemers
DOI: 10.2174/187152711794653760
Published on: 01 March, 2012

Homocysteine in Neurological Disease: A Marker or a Cause?

Volume:10   Issue: 3
Pp: 361-369
Suruchi Khanna, Puneet Kapoor, K. K. Pillai and Divya Vohora
DOI: 10.2174/187152711794653797
Published on: 01 March, 2012

Pharmacotherapy and Prevention of Vascular Dementia

Volume:10   Issue: 3
Pp: 370-390
A. Moretti, A. Gorini and R. F. Villa
DOI: 10.2174/187152711794653832
Published on: 01 March, 2012

Targeting TNF-Alpha to Elucidate and Ameliorate Neuroinflammation in Neurodegenerative Diseases

Volume:10   Issue: 3
Pp: 391-403
Kathryn A. Frankola, Nigel H. Greig, Weiming Luo and David Tweedie
DOI: 10.2174/187152711794653751
Published on: 01 March, 2012

Hemichannels in the Neurovascular Unit and White Matter Under Normal and Inflamed Conditions

Volume:10   Issue: 3
Pp: 404-414
Juan A. Orellana, Xavier F. Figueroa, Helmuth A. Sanchez, Susana Contreras-Duarte, Victoria Velarde and Juan C. Saez
DOI: 10.2174/187152711794653869
Published on: 01 March, 2012